Skip to main content
SpringerLink
Log in
Book cover

Obesity and Fertility pp 133–148Cite as

Contraceptive Counseling in Obese Women

  • Chapter

Abstract

Obesity continues to be a problem worldwide and is more commonly surfacing in young reproductive-age women. In obese reproductive-age women, effective contraceptive counseling can be difficult but is critical as pregnancy can carry serious maternal and neonatal morbidities. The high association of medical comorbidities makes individualized counseling essential. Several tools have been developed to assist clinicians in counseling these women. Ensuring obese women are using the most effective methods of contraception will help reduce unintended pregnancy, and subsequently obesity-related morbidities in this population.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Crane JM, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can. 2013;35(7):606–11. PubMed PMID: 23876637.

    PubMed  Google Scholar 

  2. Scott-Pillai R, Spence D, Cardwell CR, Hunter A, Holmes VA. The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011. BJOG. 2013;120(8):932–9. PubMed PMID: 23530609.

    CAS  PubMed  Google Scholar 

  3. Minsart AF, Buekens P, De Spiegelaere M, Englert Y. Neonatal outcomes in obese mothers: a population-based analysis. BMC Pregnancy Childbirth. 2013;13. PubMed PMID: 23398843. Pubmed Central PMCID: 3575268.

    Google Scholar 

  4. Cnattingius S, Villamor E, Johansson S, Edstedt Bonamy AK, Persson M, Wikstrom AK, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013;309(22):2362–70. PubMed PMID: 23757084.

    Article  CAS  PubMed  Google Scholar 

  5. American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 549: obesity in pregnancy. Obstet Gynecol. 2013;121(1):213–7. PubMed PMID: 23262963.

    Google Scholar 

  6. Curtis KM, Tepper NK, Marchbanks PA. Putting risk into perspective: the US medical eligibility criteria for contraceptive use. Rev Endocr Metab Disord. 2011;12(2):119–25. PubMed PMID: 21541854.

    PubMed  Google Scholar 

  7. Division of Reproductive Health NCfCDP, Health Promotion CfDC, Prevention. U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013;62(RR-05):1–60. PubMed PMID: 23784109.

    Google Scholar 

  8. Lessard LN, Karasek D, Ma S, Darney P, Deardorff J, Lahiff M, et al. Contraceptive features preferred by women at high risk of unintended pregnancy. Perspect Sex Reprod Health. 2012;44(3):194–200. PubMed PMID: 22958664.

    PubMed  Google Scholar 

  9. Grimes DA, Shields WC. Family planning for obese women: challenges and opportunities. Contraception. 2005;72(1):1–4. PubMed PMID: 15964284.

    Article  PubMed  Google Scholar 

  10. Trussell J, Schwarz EB, Guthrie K. Obesity and oral contraceptive pill failure. Contraception. 2009;79(5):334–8. PubMed PMID: 19341843. Pubmed Central PMCID: 3638205.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Mornar S, Chan LN, Mistretta S, Neustadt A, Martins S, Gilliam M. Pharmacokinetics of the etonogestrel contraceptive implant in obese women. Am J Obstet Gynecol. 2012;207(2):110 e1–6. PubMed PMID: 22717269.

    Google Scholar 

  12. Society of Family Planning, Higginbotham S. Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091. Contraception. 2009;80(6):583–90. PubMed PMID: 19913155.

    Google Scholar 

  13. Segall-Gutierrez P, Taylor D, Liu X, Stanzcyk F, Azen S, Mishell Jr DR. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously. Contraception. 2010;81(6):487–95. PubMed PMID: 20472115.

    Article  CAS  PubMed  Google Scholar 

  14. Westhoff CL, Torgal AH, Mayeda ER, Petrie K, Thomas T, Dragoman M, et al. Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women. Am J Obstet Gynecol. 2012;207:39.e1–6. PubMed PMID: 22727346. Pubmed Central PMCID: 3403702.

    CAS  Google Scholar 

  15. McNicholas C, Zhao Q, Secura G, Allsworth JE, Madden T, Peipert JF. Contraceptive failures in overweight and obese combined hormonal contraceptive users. Obstet Gynecol. 2013;121(3):585–92. PubMed PMID: 23635622.

    PubMed Central  PubMed  Google Scholar 

  16. Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Secura GM. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol. 2012;120(1):21–6. PubMed PMID: 22678035.

    PubMed Central  CAS  PubMed  Google Scholar 

  17. Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol. 2013;20(5):437–44. PubMed PMID: 23817170.

    CAS  PubMed  Google Scholar 

  18. Hatcher R, Trussel J, Nelson A, Cates W, Kowal D, Policar M. Contraceptive technology. 20th ed. New York: Ardent Media; 2011.

    Google Scholar 

  19. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990;97(8):690–4. PubMed PMID: 2119218.

    CAS  PubMed  Google Scholar 

  20. Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception. 2003;67(2):87–91. PubMed PMID: 12586318.

    Article  CAS  PubMed  Google Scholar 

  21. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 2002;65(2):129–32. PubMed PMID: 11927115.

    Article  CAS  PubMed  Google Scholar 

  22. Stoegerer-Hecher E, Kirchengast S, Huber JC, Hartmann B. Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: cross-sectional study in a Central European district. Gynecol Endocrinol. 2012;28(2):119–24. PubMed PMID: 21848413.

    PubMed  Google Scholar 

  23. Wildemeersch D, Anderson E, Lambein K, Pauwels P, Dhont M. Successful treatment of early endometrial carcinoma by local delivery of levonorgestrel: a case report. Obstet Gynecol Int. 2010;2010:431950. PubMed PMID: 20981240. Pubmed Central PMCID: 2963141.

    PubMed Central  CAS  PubMed  Google Scholar 

  24. Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N. IUD use and the risk of endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2002;105(2):166–9. PubMed PMID: 12381481.

    PubMed  Google Scholar 

  25. Orbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008;111(1):68–73. PubMed PMID: 18684496.

    PubMed  Google Scholar 

  26. Minig L, Franchi D, Boveri S, Casadio C, Bocciolone L, Sideri M. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol. 2011;22(3):643–9. PubMed PMID: 20876910.

    CAS  PubMed  Google Scholar 

  27. Brown AJ, Westin SN, Broaddus RR, Schmeler K. Progestin intrauterine device in an adolescent with grade 2 endometrial cancer. Obstet Gynecol. 2012;119(2 Pt 2):423–6. PubMed PMID: 22270425. Pubmed Central PMCID: 3266511.

    PubMed Central  PubMed  Google Scholar 

  28. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception. 2009;79(1):5–14. PubMed PMID: 19041435. Pubmed Central PMCID: 3638200.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Alvarez F, Brache V, Fernandez E, Guerrero B, Guiloff E, Hess R, et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril. 1988;49(5):768–73. PubMed PMID: 3360166.

    CAS  PubMed  Google Scholar 

  30. Veldhuis HM, Vos AG, Lagro-Janssen AL. Complications of the intrauterine device in nulliparous and parous women. Eur J Gen Pract. 2004;10(3):82–7. PubMed PMID: 15534571.

    CAS  PubMed  Google Scholar 

  31. Group ECW. Intrauterine devices and intrauterine systems. Hum Reprod Update. 2008;14(3):197–208. PubMed PMID: 18400840.

    Google Scholar 

  32. Mechanism of action, safety and efficacy of intrauterine devices. Report of a WHO Scientific Group. World Health Organization technical report series. 1987;753:1–91. PubMed PMID: 3118580.

    Google Scholar 

  33. Sezer SD, Odabasi AR, Kucuk M, Yuksel H. Lost intrauterine contraceptive device inserted 42 years before: a case report. Clin Exp Obstet Gynecol. 2011;38(1):90–3. PubMed PMID: 21485737.

    CAS  PubMed  Google Scholar 

  34. Markovitch O, Klein Z, Gidoni Y, Holzinger M, Beyth Y. Extrauterine mislocated IUD: is surgical removal mandatory? Contraception. 2002;66(2):105–8. PubMed PMID: 12204783.

    Article  PubMed  Google Scholar 

  35. Haimov-Kochman R, Doviner V, Amsalem H, Prus D, Adoni A, Lavy Y. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation. Hum Reprod. 2003;18(5):990–3. PubMed PMID: 12721174.

    CAS  PubMed  Google Scholar 

  36. Van den Bosch T, Donders GG, Riphagen I, Debois P, Ameye L, De Brabanter J, et al. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant. Ultrasound Obstet Gynecol. 2002;20(4):377–80. PubMed PMID: 12383321.

    PubMed  Google Scholar 

  37. Ciangura C, Corigliano N, Basdevant A, Mouly S, Decleves X, Touraine P, et al. Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports. Contraception. 2011;84(6):649–51. PubMed PMID: 22078197.

    Article  CAS  PubMed  Google Scholar 

  38. McNicholas C, Maddipati R, Swor E, Zhao Q, Peipert JF. Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the U.S. Food and Drug Administration-Approved Duration. Obstet Gynecol. 2015;125(3):599–604.

    Google Scholar 

  39. Weisberg E, Hickey M, Palmer D, O’Connor V, Salamonsen LA, Findlay JK, et al. A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Hum Reprod. 2009;24(8):1852–61. PubMed PMID: 19369294. Pubmed Central PMCID: 2710284.

    PubMed Central  CAS  PubMed  Google Scholar 

  40. Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, et al. Timing of onset of contraceptive effectiveness in Depo-Provera users. II Effects on ovarian function. Fertil Steril. 1998;70(5):817–20. PubMed PMID: 9806559.

    CAS  PubMed  Google Scholar 

  41. Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, et al. Timing of onset of contraceptive effectiveness in Depo-Provera users: part I. Changes in cervical mucus. Fertil Steril. 1998;69(2):252–7. PubMed PMID: 9496338.

    CAS  PubMed  Google Scholar 

  42. Croxatto HB. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception. 2002;65(1):21–7. PubMed PMID: 11861052.

    Article  CAS  PubMed  Google Scholar 

  43. Mishell Jr DR. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41(5 Suppl):381–90. PubMed PMID: 8725700.

    CAS  PubMed  Google Scholar 

  44. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998–2007. PubMed PMID: 22621627.

    CAS  PubMed  Google Scholar 

  45. Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell Jr DR. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception. 2004;70(1):11–8. PubMed PMID: 15208047.

    Article  CAS  PubMed  Google Scholar 

  46. Bulletins-Gynecology ACoP. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453–72. PubMed PMID: 16738183.

    Google Scholar 

  47. Schwallie PC, Assenzo JR. Contraceptive use—efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril. 1973;24(5):331–9. PubMed PMID: 4698589.

    CAS  PubMed  Google Scholar 

  48. Belsey EM. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception. 1988;38(2):181–206. PubMed PMID: 2971505.

    Article  CAS  PubMed  Google Scholar 

  49. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer. 1991;49(2):191–5.

    Google Scholar 

  50. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer. 1991;49(2):186–90.

    Google Scholar 

  51. Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med. 2006;160(1):40–5. PubMed PMID: 16389209.

    PubMed  Google Scholar 

  52. Curtis KM, Ravi A, Gaffield ML. Progestogen-only contraceptive use in obese women. Contraception. 2009;80(4):346–54. PubMed PMID: 19751857.

    Article  CAS  PubMed  Google Scholar 

  53. Mangan SA, Larsen PG, Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2002;15(2):79–82. PubMed PMID: 12057528.

    PubMed  Google Scholar 

  54. Cundy T, Cornish J, Roberts H, Elder H, Reid IR. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol. 1998;92(4 Pt 1):569–73. PubMed PMID: 9764630.

    CAS  PubMed  Google Scholar 

  55. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002;13(5):581–7. PubMed PMID: 12192229.

    Article  PubMed  Google Scholar 

  56. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005;159(2):139–44. PubMed PMID: 15699307.

    PubMed  Google Scholar 

  57. Clark MK, Sowers MR, Nichols S, Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2004;82(6):1580–6. PubMed PMID: 15589863.

    CAS  PubMed  Google Scholar 

  58. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat. 2010;23(29):1–44. PubMed PMID: 20939159.

    Google Scholar 

  59. Edelman AB, Carlson NE, Cherala G, Munar MY, Stouffer RL, Cameron JL, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception. 2009;80(2):119–27. PubMed PMID: 19631786. Pubmed Central PMCID: 2736633.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Westhoff CL, Torgal AH, Mayeda ER, Pike MC, Stanczyk FZ. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 2010;81(6):474–80. PubMed PMID: 20472113. Pubmed Central PMCID: 3522459.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol. 2010;116(2 Pt 1):275–83. PubMed PMID: 20664386.

    PubMed  Google Scholar 

  62. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77(2 Suppl 2):S13–8. PubMed PMID: 11849631.

    PubMed  Google Scholar 

  63. Dragoman M, Petrie K, Torgal A, Thomas T, Cremers S, Westhoff CL. Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women. Contraception. 2013;87(4):432–6. PubMed PMID: 23312933. Pubmed Central PMCID: 3606661.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Dinger JC, Cronin M, Mohner S, Schellschmidt I, Minh TD, Westhoff C. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2009;201(3):263.e1–9. PubMed PMID: 19481720.

    Google Scholar 

  65. Holt VL, Cushing-Haugen KL, Daling JR. Body weight and risk of oral contraceptive failure. Obstet Gynecol. 2002;99(5 Pt 1):820–7. PubMed PMID: 11978293.

    PubMed  Google Scholar 

  66. Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol. 2005;105(1):46–52. PubMed PMID: 15625141.

    PubMed  Google Scholar 

  67. Brunner LR, Hogue CJ. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth. Ann Epidemiol. 2005;15(7):492–9. PubMed PMID: 16029841.

    PubMed  Google Scholar 

  68. Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2008;(1):CD003552. PubMed PMID: 18254023.

    Google Scholar 

  69. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton 3rd LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–706. PubMed PMID: 16287790.

    PubMed  Google Scholar 

  70. McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception. 1994;50(6 Suppl 1):S1–195. PubMed PMID: 10226677.

    CAS  PubMed  Google Scholar 

  71. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909–17. PubMed PMID: 16234497.

    Article  CAS  PubMed  Google Scholar 

  72. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132(6):2253–71. PubMed PMID: 17498516.

    Article  PubMed  Google Scholar 

  73. Practice Committee of American Society for Reproductive Medicine. Obesity and reproduction: an educational bulletin. Fertil Steril. 2008;90(5 Suppl):S21–9. PubMed PMID: 19007633.

    Google Scholar 

  74. Practice ACoG. ACOG committee opinion. Number 319, October 2005. The role of obstetrician-gynecologist in the assessment and management of obesity. Obstet Gynecol. 2005;106(4):895–9. PubMed PMID: 16199657.

    Google Scholar 

  75. Gerrits EG, Ceulemans R, van Hee R, Hendrickx L, Totte E. Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg. 2003;13(3):378–82. PubMed PMID: 12841897.

    PubMed  Google Scholar 

  76. Victor A, Odlind V, Kral JG. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass. Gastroenterol Clin North Am. 1987;16(3):483–91. PubMed PMID: 2449395.

    CAS  PubMed  Google Scholar 

  77. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 105: bariatric surgery and pregnancy. Obstet Gynecol. 2009;113(6):1405–13. PubMed PMID: 19461456.

    Google Scholar 

  78. Merhi ZO. Weight loss by bariatric surgery and subsequent fertility. Fertil Steril. 2007;87(2):430–2. PubMed PMID: 17113090.

    PubMed  Google Scholar 

  79. Merhi ZO. Bariatric surgery and subsequent sexual function. Fertil Steril. 2007;87(3):710–1. PubMed PMID: 17123521.

    PubMed  Google Scholar 

  80. Hillman JB, Miller RJ, Inge TH. Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients. J Womens Health. 2011;20(4):533–8. PubMed PMID: 21413894. Pubmed Central PMCID: 3075047.

    Google Scholar 

  81. Mody SK, Hacker MR, Dodge LE, Thornton K, Schneider B, Haider S. Contraceptive counseling for women who undergo bariatric surgery. J Womens Health. 2011;20(12):1785–8. PubMed PMID: 21988600.

    Google Scholar 

  82. Jones J, Mosher WD, Daniels K. Current contraceptive use in the United States, 2006–2010, and changes in patterns of use since 1995, National Health Statistics Reports, 2012, No. 60.

    Google Scholar 

  83. Schraudenbach A, McFall S. Contraceptive use and contraception type in women by body mass index category. Womens Health Issues. 2009;19(6):381–9. PubMed PMID: 19879452.

    PubMed  Google Scholar 

  84. Peterson HB. Sterilization. Obstet Gynecol. 2008;111(1):189–203. PubMed PMID: 18165410.

    PubMed  Google Scholar 

  85. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174(4):1161–8. discussion 8–70. PubMed PMID: 8623843.

    CAS  PubMed  Google Scholar 

  86. American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 133: benefits and risks of sterilization. Obstet Gynecol. 2013;121(2 Pt 1):392–404. PubMed PMID: 23344305.

    Google Scholar 

  87. Rodriguez MI, Edelman AB, Kapp N. Postpartum sterilization with the titanium clip: a systematic review. Obstet Gynecol. 2011;118(1):143–7. PubMed PMID: 21691172.

    PubMed  Google Scholar 

  88. Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod. 2003;18(6):1223–30. PubMed PMID: 12773450.

    PubMed  Google Scholar 

  89. Rodriguez MI, Seuc A, Sokal DC. Comparative efficacy of postpartum sterilisation with the titanium clip versus partial salpingectomy: a randomised controlled trial. BJOG. 2013;120(1):108–12. PubMed PMID: 22925277.

    CAS  PubMed  Google Scholar 

  90. Bradley LD, Price TM, Van Herendael BJ, Cayuela E. Long-term follow-up of hysteroscopic sterilization with the Essure micro-insert. J Minim Invasive Gynecol. 2009;16(6 suppl):S14–5.

    Google Scholar 

  91. Povedano B, Arjona JE, Velasco E, Monserrat JA, Lorente J, Castelo-Branco C. Complications of hysteroscopic Essure((R)) sterilisation: report on 4306 procedures performed in a single centre. BJOG. 2012;119(7):795–9. PubMed PMID: 22360159.

    CAS  PubMed  Google Scholar 

  92. Kovacs GT, Krins AJ. Female sterilisations with Filshie clips: what is the risk failure? A retrospective survey of 30,000 applications. J Fam Plann Reprod Health Care. 2002;28(1):34–5. PubMed PMID: 16259814.

    PubMed  Google Scholar 

  93. Jamieson DJ, Hillis SD, Duerr A, Marchbanks PA, Costello C, Peterson HB. Complications of interval laparoscopic tubal sterilization: findings from the United States collaborative review of sterilization. Obstet Gynecol. 2000;96(6):997–1002. PubMed PMID: 11084192.

    CAS  PubMed  Google Scholar 

  94. Chi IC, Wilkens L. Interval tubal sterilization in obese women—an assessment of risks. Am J Obstet Gynecol. 1985;152(3):292–7. PubMed PMID: 4003474.

    CAS  PubMed  Google Scholar 

  95. Dehlendorf C, Levy K, Kelley A, Grumbach K, Steinauer J. Women’s preferences for contraceptive counseling and decision making. Contraception. 2013;88(2):250–6. PubMed PMID: 23177265.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Research, Washington University School of Medicine, 4533 Clayton Ave, St. Louis, MO, 63110, USA

    Colleen McNicholas DO, MSci

  2. Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA

    Rachel Zigler MD & Tessa Madden MD, MPH

Authors
  1. Colleen McNicholas DO, MSci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachel Zigler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tessa Madden MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Colleen McNicholas DO, MSci .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA

    Emily S. Jungheim

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

McNicholas, C., Zigler, R., Madden, T. (2015). Contraceptive Counseling in Obese Women. In: Jungheim, E. (eds) Obesity and Fertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2611-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2611-4_9

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2610-7

  • Online ISBN: 978-1-4939-2611-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation